Angiotensin Ii + Aliskiren Hemifumarate Interaction
Majorinteraction on record
Description
Concomitant use with ARBs is contraindicated in diabetic patients and associated with increased risk of hypotension, hyperkalemia, and acute renal failure in others.
Mechanism
Dual blockade of RAAS
Source: NLP:aliskiren hemifumarate